This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Endoscopic Dilation is a minimally invasive procedure that is used to treat certain digestive disorders. It involves the use of a flexible tube with a camera and dilator attached to the end. The tube is inserted through the mouth and into the digestive tract, where it is used to widen the walls of a narrowed section or valve, allowing for better digestion. The procedure is generally performed as an outpatient procedure and does not require general anesthesia. Endoscopic Dilation is most commonly used to treat conditions such as strictures, achalasia, and esophageal webs. Strictures are narrowings of the esophagus or other parts of the digestive tract which can cause difficulty swallowing or persistent chest pain. Achalasia is a disorder of the lower esophageal sphincter that prevents food from entering the stomach. Esophageal webs are thin layers of tissue that form in the esophagus and can lead to difficulty swallowing and chest pain. The benefits of Endoscopic Dilation include improved digestion, reduced symptoms, and decreased risk of further complications. During the procedure, the doctor will insert the endoscope and dilator into the esophagus or other part of the digestive tract. The dilator will then gradually expand the walls of the narrowed area, allowing for better digestion. After treatment, patients may experience improved swallowing ability, reduced chest pain or difficulty breathing, and improved quality of life. Endoscopic Dilation is generally safe but there are some possible risks associated with the procedure such as bleeding, perforation of the esophagus or other parts of the digestive tract, or infection. In addition, some patients may experience nausea, vomiting, or abdominal discomfort during or after treatment. Patients should discuss any concerns about potential risks with their doctor prior to beginning Endoscopic Dilation.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States